Cargando…

Practice Patterns of Induction Therapy in Severe Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Detalles Bibliográficos
Autores principales:	Aqeel, Faten, Xu, Lillian, Tomar, Ojaswi, Duchen, Jessica, Li, Tingting, Geetha, Duvuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727511/ https://www.ncbi.nlm.nih.gov/pubmed/36506242 http://dx.doi.org/10.1016/j.ekir.2022.08.029

Ejemplares similares

Repeat Kidney Biopsies in Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Clinical and Histologic Progression
por: Aqeel, Faten, et al.
Publicado: (2023)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Shah, Shivani, et al.
Publicado: (2017)

Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
por: Kant, Sam, et al.
Publicado: (2021)

Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
por: Kant, Sam, et al.
Publicado: (2022)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
por: Michailidou, Despina, et al.
Publicado: (2022)

Immune checkpoint inhibitors as potential triggers for ANCA vasculitis
por: Aqeel, Faten, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2021)

Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan
por: Aqeel, Faten, et al.
Publicado: (2023)

Looks can be Deceiving: A Challenging Case of Anti-Neutrophil Cytoplasmic Autoantibody Associated Vasculitis
por: Ramadan, Bashar, et al.
Publicado: (2021)

Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
por: Yang, Jiajin, et al.
Publicado: (2016)

Successful treatment for thrombotic thrombocytopenic purpura complicated with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis
por: Yamauchi, Yoko, et al.
Publicado: (2010)

Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System
por: Little, Mark A., et al.
Publicado: (2012)

Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis
por: Mendoza, Carmen E., et al.
Publicado: (2019)

Clinicopathological Characteristics and Influencing Factors of Renal Vascular Lesions in Anti-neutrophil Cytoplasmic Autoantibody-Related Renal Vasculitis
por: Wang, Ruiqiang, et al.
Publicado: (2021)

Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Zhang, Naidan, et al.
Publicado: (2022)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Hellmark, Thomas, et al.
Publicado: (2019)

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Sun, Xiao-Jing, et al.
Publicado: (2023)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis
por: Ghosh, Jyotsna, et al.
Publicado: (2021)

Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy
por: Gapud, Eric J, et al.
Publicado: (2018)

Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Lazarus, B., et al.
Publicado: (2016)

Current and novel biomarkers in anti-neutrophil cytoplasm-associated vasculitis
por: Draibe, Juliana Bordignon, et al.
Publicado: (2016)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
por: Salama, Alan D.
Publicado: (2019)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Weng, Cheng-Hua, et al.
Publicado: (2019)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
por: Binda, Valentina, et al.
Publicado: (2021)

Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis
por: Alba, Marco A., et al.
Publicado: (2022)

Clinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center
por: Pu, Lei, et al.
Publicado: (2017)

Clinicopathological characteristics and outcomes of anti-neutrophil cytoplasmic autoantibody-related renal vasculitis with hyperuricemia: a retrospective case-control study
por: Wang, Ruiqiang, et al.
Publicado: (2021)

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Geetha, Duvuru, et al.
Publicado: (2018)

Renal Involvement of CD20-Negative Intravascular Large B Cell Lymphoma with Neurological Manifestations
por: Aqeel, Faten, et al.
Publicado: (2022)

Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies
por: Xu, Peng-Cheng, et al.
Publicado: (2012)

Improvement of Alveolar Hemorrhaging in an Elderly and Renally Impaired Patient with Relapsing Anti-neutrophil Cytoplasmic Autoantibody-associated Vasculitis by Single Infusion of Rituximab
por: Oda, Keiko, et al.
Publicado: (2018)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Robson, Joanna C., et al.
Publicado: (2017)

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis (AAV) Restricted to the Limbs
por: Ojima, Yoshie, et al.
Publicado: (2017)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
por: Tsukui, Daisuke, et al.
Publicado: (2021)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
por: Wu, Haiting, et al.
Publicado: (2022)

Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitis
por: Avello, Alejandro, et al.
Publicado: (2020)

Tozinameran: Anti neutrophil cytoplasmic antibody-associated vasculitis: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t7j8aph0i3jfuq9ik9i5j50trh